Scope of Ultra-CAR-T therapy in myeloma, PCOS management with supplements & understanding m-RNA vaccines
JUNE 1, 2021
 RECENT Talks

UltraCAR-T Therapy – Scope & Possibilities in Multiple Myeloma Management

with  Dr. David Sallman 
May 17, 2021, 10 AM EST
LISTEN

Ongoing clinical trials are investigating the safety and efficacy of a new type of CAR T (Chimeric antigen receptor T-cells) therapy called UltraCAR-T therapy for myeloid malignancies. Unlike current CAR T cells, which utilize viruses to attach the CAR to the T cells, UltraCAR-T uses a non-viral gene delivery system and has a rapid turnaround compared to traditional CAR-T cells manufacturing process. We are talking to Dr. David Sallman, a hematologist in the Malignant Hematology Program at Moffitt Cancer Center to learn more about the new type of CAR-T cells, their action, side effects and scope of their use in treating multiple myeloma. 

Panelists
Dr. David Sallman
Gary Petersen
Jack Aiello
Yelak Biru
Priya Menon
April 16, 2021, 2:30 PM EST
LISTEN
Diet and medical nutrition therapy is a crucial part of PCOS management. The Academy of Nutrition and Dietetics’ Nutrition Care Manual includes evidence-based medical nutrition therapy guidelines for adolescents and young adults with PCOS which indicates that proper management of macronutrient intake and supplementation of a few micronutrients are helpful in reducing symptoms of PCOS such as bloating, male-pattern baldness, acne, irregular menstruation, hyperandrogenism and more. However, one size does not fit all and personalised nutrition guidance is recommended for all women. What supplements have been shown to regulate periods and improve fertility? Which nutrient reduces excess hair growth and acne? What does evidence tell us? To get answers to these questions and more, we talked to registered dietician Angela Grassi, a PCOS survivor herself who is an internationally known nutrition and health expert on PCOS, author of several books on PCOS and founder of PCOS Nutrition Center. PCOS patient advocate Lisa Rosenthal of RMACT helped guide the discussion from the patient panel.

Panelists
Angela Grassi
Lisa Rosenthal
Madison Lip
Ashley Levinson 
Shweta Mishra
April 5, 2021, 10 AM EST
LISTEN
Messenger RNA vaccines, also called mRNA vaccines, are some of the first COVID-19 vaccines authorized for use in the United States. mRNA vaccines are a new type of vaccine to protect against infectious diseases. They teach the cells of our body to make a protein that triggers an immune response. This immune response leads to the production of antibodies which protects us from getting infected if the real virus enters our body. We are sitting down with Dr. Drew Weissman, who with his former colleague Katalin Kariko, developed the mRNA technology enabling the creation of the Covid-19 mRNA vaccines, to learn more about the science behind mRNA, the technology and his journey. Dr. Weissman is a professor of Infectious Diseases in Penn’s Perelman School of Medicine and has been working on using RNA in vaccines for more than 15 years.








Panelists
Dr. Drew Weissman
David Stanley
Matt Goldman
Dr. Herbert Geller
Priya Menon
Subscribe to CureTalks YouTube channel here.
Our Picks
Avatar
TrialX Editor
powerfunction@gmail.com